Dog Oral Melanoma Treatment Advances

Oral melanoma is the most common oral tumor in dogs, and recent immunotherapy advances offer hope for a historically aggressive and rapidly fatal cancer.

Key Facts

Oral melanoma accounts for up to 40% of all canine oral tumors
The tumor is highly locally invasive and metastasizes early to lymph nodes and lungs
Median survival with surgery alone is 5 to 7 months
The USDA-approved canine melanoma vaccine (Oncept) uses DNA encoding human tyrosinase
The vaccine has extended survival times in some studies
Radiation therapy is used when surgical margins are inadequate
Staging with chest X-rays and lymph node aspiration guides treatment planning
Dark-pigmented breeds including Chow Chows and Miniature Poodles are predisposed

Welfare Considerations

Oral melanoma causes significant suffering through locally destructive growth that makes eating painful and difficult. Without treatment, dogs deteriorate rapidly as the tumor invades the jaw and spreads to the lungs. The fear of eating and difficulty maintaining weight creates ongoing distress. Immunotherapy with the Oncept vaccine represents a meaningful welfare advance by potentially extending comfortable life. Palliative care when curative treatment is not possible should focus on maintaining comfortable eating and quality of life.

What You Can Do

Seek early veterinary evaluation for any oral mass in your dog
Ask about the Oncept melanoma vaccine as part of a multimodal treatment plan
Stage the tumor fully before deciding on treatment options
Discuss quality of life goals openly with your oncologist
Support veterinary cancer research including immunotherapy trials